{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T13:21:47Z","timestamp":1774272107681,"version":"3.50.1"},"reference-count":69,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Shandong Provincial Medical and Health Science and Technology Project","award":["202303010946"],"award-info":[{"award-number":["202303010946"]}]},{"name":"Pharmacology, Toxicology and Cardiovascular Translational Research Project","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Research Project on the Mechanism of Tibetan Medicine Rannasangpei Pill","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Atherosclerosis (AS) is by far the most frequent underlying cause of atherosclerotic cardiovascular disease. Recently, sodium-glucose cotransporter 2 (SGLT2) inhibitors stand out for their anti-atherosclerotic effects. The present study was conducted to explore the potential genetic and molecular mechanisms of empagliflozin, a selective SGLT2 inhibitor, in preventing AS, and the correlation of empagliflozin-related hub genes with immune cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In our study, pharmacology platforms were accessed to identify the empagliflozin-related genes (ERGs). AS datasets GSE100927 and GSE43292 were downloaded from the public GEO database to identify AS-differentially expressed genes (AS-DEGs). Furthermore, the empagliflozin-related DEGs (ERDEGs) were obtained by intersecting AS-DEGs and ERGs. ERDEGs were further analyzed for Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses. The protein-protein interaction (PPI) network was constructed to screen for hub genes, which were subjected to regulatory network construction, ROC curve plotting, as well as validation analysis, correlation and Friends analysis, and CIBERSORT and ssGSEA analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 33 genes were identified as ERDEGs, among which the empagliflozin-related hub genes were identified to be IL1B, EGFR, ERBB2, JAK2, SYK, and LGALS3 in AS. Furthermore, in terms of the characteristics of immune cells, there were significant correlations between ERBB2 and CD8\u2009+\u2009T cells, IL1B and resting mast cells, LGALS3 and eosinophils, as well as JAK2 and CD56dim NK.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our network pharmacology and bioinformatics analyses provide a comprehensive understanding of the potential mechanisms of empagliflozin in AS at the genomic level, with the discovery of significant correlations between the screened hub genes and various immune cell subsets.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0339956","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T18:36:17Z","timestamp":1768588577000},"page":"e0339956","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification of empagliflozin-related hub genes in atherosclerosis and their correlations with immune infiltration: Network pharmacology and bioinformatics analyses"],"prefix":"10.1371","volume":"21","author":[{"given":"Yicheng","family":"Rong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2024-6645","authenticated-orcid":true,"given":"Xinyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1665-2727","authenticated-orcid":true,"given":"Le","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"issue":"10","key":"pone.0339956.ref001","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1161\/CIRCRESAHA.118.313816","article-title":"Atherosclerosis","volume":"123","author":"K Kobiyama","year":"2018","journal-title":"Circulation Research"},{"issue":"6","key":"pone.0339956.ref002","first-page":"256","article-title":"Atherosclerosis and inflammation. New therapeutic approaches","volume":"155","author":"J Pedro-Botet","year":"2020","journal-title":"Med Clin (Barc)"},{"issue":"39","key":"pone.0339956.ref003","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1093\/eurheartj\/ehad472","article-title":"Women, lipids, and atherosclerotic cardiovascular disease: A call to action from the European Atherosclerosis Society","volume":"44","author":"JE Roeters van Lennep","year":"2023","journal-title":"Eur Heart J"},{"issue":"2","key":"pone.0339956.ref004","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1161\/CIRCRESAHA.120.315890","article-title":"The molecular basis of predicting atherosclerotic cardiovascular disease risk","volume":"128","author":"M Nayor","year":"2021","journal-title":"Circulation Research"},{"issue":"10","key":"pone.0339956.ref005","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/jamacardio.2017.2762","article-title":"Cost-effectiveness of evolocumab therapy for reducing cardiovascular events in patients with atherosclerotic cardiovascular disease","volume":"2","author":"GC Fonarow","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"18","key":"pone.0339956.ref006","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1093\/eurheartj\/ehaa956","article-title":"The association of amputations and peripheral artery disease in patients with type 2 diabetes mellitus receiving sodium-glucose cotransporter type-2 inhibitors: Real-world study","volume":"42","author":"SK Paul","year":"2021","journal-title":"Eur Heart J"},{"issue":"12","key":"pone.0339956.ref007","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S2213-8587(20)30344-2","article-title":"Effects of empagliflozin on first and recurrent clinical events in patients with type 2 diabetes and atherosclerotic cardiovascular disease: A secondary analysis of the EMPA-REG OUTCOME trial","volume":"8","author":"DK McGuire","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"pone.0339956.ref008","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.2147\/JIR.S309427","article-title":"Empagliflozin alleviates atherosclerosis progression by inhibiting inflammation and sympathetic activity in a normoglycemic mouse model","volume":"14","author":"Y Liu","year":"2021","journal-title":"J Inflamm Res"},{"key":"pone.0339956.ref009","doi-asserted-by":"crossref","first-page":"173040","DOI":"10.1016\/j.ejphar.2020.173040","article-title":"Empagliflozin ameliorates endothelial dysfunction and suppresses atherogenesis in diabetic apolipoprotein E-deficient mice","volume":"875","author":"B Ganbaatar","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"pone.0339956.ref010","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijcard.2022.07.048","article-title":"Empagliflozin inhibits macrophage inflammation through AMPK signaling pathway and plays an anti-atherosclerosis role","volume":"367","author":"J Fu","year":"2022","journal-title":"Int J Cardiol"},{"issue":"1","key":"pone.0339956.ref011","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/jcm11010137","article-title":"Effects of SGLT2 inhibitors on atherosclerosis: Lessons from cardiovascular clinical outcomes in type 2 diabetic patients and basic researches","volume":"11","author":"J Xu","year":"2021","journal-title":"J Clin Med"},{"key":"pone.0339956.ref012","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.2147\/DDDT.S409530","article-title":"Elucidating the mechanism of agrimonolide in treating colon cancer based on network pharmacology","volume":"17","author":"L Yu","year":"2023","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"pone.0339956.ref013","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tips.2021.11.004","article-title":"Network pharmacology: Curing causal mechanisms instead of treating symptoms","volume":"43","author":"C Nogales","year":"2022","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"pone.0339956.ref014","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbad120","article-title":"Machine learning for synergistic network pharmacology: A comprehensive overview","volume":"24","author":"F Noor","year":"2023","journal-title":"Brief Bioinform"},{"key":"pone.0339956.ref015","article-title":"Analysis and validation of hub genes in blood monocytes of postmenopausal osteoporosis patients","volume":"12","author":"YX Deng","year":"2022","journal-title":"Front Endocrinol"},{"key":"pone.0339956.ref016","article-title":"PubChem in 2021: New data content and improved web interfaces","volume":"49","author":"S Kim","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"pone.0339956.ref017","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules","volume":"47","author":"A Daina","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"pone.0339956.ref018","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaa1084","article-title":"Integration of the Drug-Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts","volume":"49","author":"SL Freshour","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"pone.0339956.ref019","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"P Shannon","year":"2003","journal-title":"Genome Res"},{"key":"pone.0339956.ref020","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkac833","article-title":"Comparative toxicogenomics database (CTD): Update 2023","volume":"51","author":"AP Davis","year":"2023","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"pone.0339956.ref021","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12920-022-01373-y","article-title":"Integrated analysis and exploration of potential shared gene signatures between carotid atherosclerosis and periodontitis","volume":"15","author":"Y Zeng","year":"2022","journal-title":"BMC Med Genomics"},{"issue":"17","key":"pone.0339956.ref022","doi-asserted-by":"crossref","first-page":"6960","DOI":"10.18632\/aging.102231","article-title":"TPM2 as a potential predictive biomarker for atherosclerosis","volume":"11","author":"L-B Meng","year":"2019","journal-title":"Aging (Albany NY)"},{"issue":"14","key":"pone.0339956.ref023","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1093\/bioinformatics\/btm254","article-title":"GEOquery: A bridge between the Gene Expression Omnibus (GEO) and BioConductor","volume":"23","author":"S Davis","year":"2007","journal-title":"Bioinformatics"},{"key":"pone.0339956.ref024","article-title":"NCBI GEO: Archive for functional genomics data sets--update","volume":"41","author":"T Barrett","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"pone.0339956.ref025","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","article-title":"The sva package for removing batch effects and other unwanted variation in high-throughput experiments","volume":"28","author":"JT Leek","year":"2012","journal-title":"Bioinformatics"},{"issue":"7","key":"pone.0339956.ref026","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"ME Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"pone.0339956.ref027","first-page":"383","article-title":"Principal Component Analysis (PCA)","volume":"99","author":"KBA Ben Salem","year":"2021","journal-title":"Tunis Med"},{"key":"pone.0339956.ref028","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"D Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"pone.0339956.ref029","article-title":"cytoHubba: Identifying hub objects and sub-networks from complex interactome","author":"C-H Chin","year":"2014","journal-title":"BMC Syst Biol"},{"key":"pone.0339956.ref030","doi-asserted-by":"crossref","first-page":"8957245","DOI":"10.1155\/2019\/8957245","article-title":"Study on the multitarget mechanism and key active ingredients of herba siegesbeckiae and volatile oil against rheumatoid arthritis based on network pharmacology","volume":"2019","author":"X Yang","year":"2019","journal-title":"Evid Based Complement Alternat Med"},{"key":"pone.0339956.ref031","article-title":"PANTHER version 14: More genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools","volume":"47","author":"H Mi","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"pone.0339956.ref032","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: Kyoto encyclopedia of genes and genomes","volume":"28","author":"S Goto MK a","year":"2000","journal-title":"Nucleic Acids Research"},{"issue":"5","key":"pone.0339956.ref033","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: An R package for comparing biological themes among gene clusters","volume":"16","author":"G Yu","year":"2012","journal-title":"OMICS"},{"issue":"43","key":"pone.0339956.ref034","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"A Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"pone.0339956.ref035","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","article-title":"Molecular signatures database (MSigDB) 3.0","volume":"27","author":"A Liberzon","year":"2011","journal-title":"Bioinformatics"},{"key":"pone.0339956.ref036","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"S H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"pone.0339956.ref037","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fonc.2020.00031","article-title":"BAG2 promotes proliferation and metastasis of gastric cancer via ERK1\/2 signaling and partially regulated by miR186","volume":"10","author":"L Sun","year":"2020","journal-title":"Front Oncol"},{"issue":"4","key":"pone.0339956.ref038","doi-asserted-by":"crossref","first-page":"8503","DOI":"10.1080\/21655979.2022.2051827","article-title":"miR-125a attenuates the malignant biological behaviors of cervical squamous cell carcinoma cells through Rad51","volume":"13","author":"Z Liu","year":"2022","journal-title":"Bioengineered"},{"key":"pone.0339956.ref039","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkz757","article-title":"miRDB: an online database for prediction of functional microRNA targets","volume":"48","author":"Y Chen","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"pone.0339956.ref040","article-title":"ChIPBase v2.0: Decoding transcriptional regulatory networks of non-coding RNAs and protein-coding genes from ChIP-seq data","volume":"45","author":"K-R Zhou","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"pone.0339956.ref041","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.gpb.2019.09.006","article-title":"hTFtarget: A comprehensive database for regulations of human transcription factors and their targets","volume":"18","author":"Q Zhang","year":"2020","journal-title":"Genomics Proteomics Bioinformatics"},{"issue":"4","key":"pone.0339956.ref042","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41592-021-01118-2","article-title":"Recapitulating early cardiogenesis in vitro","volume":"18","author":"M Mukhopadhyay","year":"2021","journal-title":"Nat Methods"},{"key":"pone.0339956.ref043","article-title":"starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data","volume":"42","author":"J-H Li","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"pone.0339956.ref044","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1093\/bioinformatics\/btq064","article-title":"GOSemSim: An R package for measuring semantic similarity among GO terms and gene products","volume":"26","author":"G Yu","year":"2010","journal-title":"Bioinformatics"},{"issue":"5","key":"pone.0339956.ref045","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"AM Newman","year":"2015","journal-title":"Nat Methods"},{"key":"pone.0339956.ref046","first-page":"10","article-title":"Identification and Verification of Immune-Related Gene Prognostic Signature Based on ssGSEA for Osteosarcoma","author":"B Xiao","year":"2020","journal-title":"Front Oncol"},{"issue":"24","key":"pone.0339956.ref047","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1161\/CIRCULATIONAHA.123.067587","article-title":"Atherosclerosis is a smooth muscle cell-driven tumor-like disease","volume":"149","author":"H Pan","year":"2024","journal-title":"Circulation"},{"key":"pone.0339956.ref048","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00350","article-title":"Altered Tregs differentiation and impaired autophagy correlate to atherosclerotic disease","volume":"11","author":"S Mandatori","year":"2020","journal-title":"Front Immunol"},{"issue":"15","key":"pone.0339956.ref049","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1161\/CIRCULATIONAHA.109.924886","article-title":"Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice","volume":"121","author":"E Smith","year":"2010","journal-title":"Circulation"},{"key":"pone.0339956.ref050","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2019.00127","article-title":"Insulin resistance is a risk factor for overall cerebral small vessel disease burden in old nondiabetic healthy adult population","volume":"11","author":"X Yang","year":"2019","journal-title":"Front Aging Neurosci"},{"key":"pone.0339956.ref051","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.atherosclerosis.2021.03.004","article-title":"c-Kit expression in smooth muscle cells reduces atherosclerosis burden in hyperlipidemic mice","volume":"324","author":"ZM Zigmond","year":"2021","journal-title":"Atherosclerosis"},{"issue":"29","key":"pone.0339956.ref052","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1093\/eurheartj\/ehad304","article-title":"Novel mechanisms and therapeutic targets in atherosclerosis: inflammation and beyond","volume":"44","author":"C Weber","year":"2023","journal-title":"Eur Heart J"},{"issue":"4","key":"pone.0339956.ref053","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/cvr\/cvy010","article-title":"Role of smooth muscle cells in vascular calcification: Implications in atherosclerosis and arterial stiffness","volume":"114","author":"AL Durham","year":"2018","journal-title":"Cardiovasc Res"},{"issue":"6","key":"pone.0339956.ref054","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1084\/jem.20080124","article-title":"An antiinflammatory role for IKKbeta through the inhibition of \u201cclassical\u201d macrophage activation","volume":"205","author":"CHY Fong","year":"2008","journal-title":"J Exp Med"},{"issue":"6008","key":"pone.0339956.ref055","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/314266a0","article-title":"Homogeneous interferon-inducing 22K factor is related to endogenous pyrogen and interleukin-1","volume":"314","author":"J Van Damme","year":"1985","journal-title":"Nature"},{"issue":"4","key":"pone.0339956.ref056","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41588-021-00803-4","article-title":"Gain-of-function variants in SYK cause immune dysregulation and systemic inflammation in humans and mice","volume":"53","author":"L Wang","year":"2021","journal-title":"Nat Genet"},{"issue":"23","key":"pone.0339956.ref057","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239232","article-title":"Galectin-3 in cardiovascular diseases","volume":"21","author":"V Blanda","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"4","key":"pone.0339956.ref058","doi-asserted-by":"crossref","first-page":"616","DOI":"10.2174\/138161282004140213155050","article-title":"Transactivation of ErbB receptors by leptin in the cardiovascular system: Mechanisms, consequences and target for therapy","volume":"20","author":"J Be\u0142towski","year":"2014","journal-title":"Curr Pharm Des"},{"issue":"13","key":"pone.0339956.ref059","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1091\/mbc.e10-01-0028","article-title":"A G{alpha}i-GIV molecular complex binds epidermal growth factor receptor and determines whether cells migrate or proliferate","volume":"21","author":"P Ghosh","year":"2010","journal-title":"Mol Biol Cell"},{"issue":"29","key":"pone.0339956.ref060","doi-asserted-by":"crossref","first-page":"17528","DOI":"10.1074\/jbc.270.29.17528","article-title":"The Jak kinases differentially associate with the \u03b1 and \u03b2 (accessory factor) chains of the interferon \u03b3 receptor to form a functional receptor unit capable of activating STAT transcription factors","volume":"270","author":"M Sakatsume","year":"1995","journal-title":"J Biol Chem"},{"issue":"8","key":"pone.0339956.ref061","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-021-00198-1","article-title":"Targeting inflammation in atherosclerosis - from experimental insights to the clinic","volume":"20","author":"O Soehnlein","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"pone.0339956.ref062","doi-asserted-by":"crossref","first-page":"1101612","DOI":"10.3389\/fgene.2023.1101612","article-title":"Bioinformatics analysis reveals the landscape of immune cell infiltration and novel immune-related biomarkers in moyamoya disease","volume":"14","author":"L Cao","year":"2023","journal-title":"Front Genet"},{"key":"pone.0339956.ref063","doi-asserted-by":"crossref","first-page":"109825","DOI":"10.1016\/j.cellsig.2020.109825","article-title":"The SGLT2 inhibitor Empagliflozin attenuates interleukin-17A-induced human aortic smooth muscle cell proliferation and migration by targeting TRAF3IP2\/ROS\/NLRP3\/Caspase-1-dependent IL-1\u03b2 and IL-18 secretion","volume":"77","author":"S Sukhanov","year":"2021","journal-title":"Cell Signal"},{"issue":"2","key":"pone.0339956.ref064","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263285","article-title":"SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes","volume":"17","author":"J Hodrea","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"pone.0339956.ref065","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1038\/s41467-024-46336-2","article-title":"PCSK9 stimulates Syk, PKC\u03b4, and NF-\u03baB, leading to atherosclerosis progression independently of LDL receptor","volume":"15","author":"D Shin","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"pone.0339956.ref066","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1161\/ATVBAHA.117.309927","article-title":"Selective EGFR (epidermal growth factor receptor) deletion in myeloid cells limits atherosclerosis-brief report","volume":"38","author":"L Zeboudj","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"13","key":"pone.0339956.ref067","article-title":"Erythroid lineage Jak2V617F expression promotes atherosclerosis through erythrophagocytosis and macrophage ferroptosis","volume":"132","author":"W Liu","year":"2022","journal-title":"J Clin Invest"},{"issue":"1","key":"pone.0339956.ref068","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s42003-022-03078-5","article-title":"Macrophage Jak2 deficiency accelerates atherosclerosis through defects in cholesterol efflux","volume":"5","author":"I Dotan","year":"2022","journal-title":"Commun Biol"},{"issue":"1","key":"pone.0339956.ref069","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1080\/21691401.2021.1873798","article-title":"Bioinformatics analysis reveals the landscape of immune cell infiltration and immune-related pathways participating in the progression of carotid atherosclerotic plaques","volume":"49","author":"L Tan","year":"2021","journal-title":"Artif Cells Nanomed Biotechnol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0339956","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T18:36:30Z","timestamp":1768588590000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0339956"}},"subtitle":[],"editor":[{"given":"Wenchao","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0339956","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]}}}